Free Trial

Best Biotechnology Stocks

Biotech stocks open the door to investing in innovation that’s shaping the future of healthcare. From pioneering drug developers to specialized firms in genetic engineering and diagnostics, this sector offers exposure to breakthroughs with the potential for transformative impact—and strong returns. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

The list below highlights some of the most widely followed biotech stocks in today’s market. It features a range of companies—from established leaders with approved therapies to up-and-coming firms advancing promising clinical pipelines. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceP/E RatioMarket CapVolumeAverage VolumeIndicator(s)
AbbVie Inc. stock logo
ABBV
AbbVie
$183.51
+0.5%
76.46$324.15 billion4.03 million6.24 millionTrending News
Analyst Downgrade
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$393.53
-1.7%
23.81$148.56 billion2.32 million1.87 millionTrending News
Dividend Announcement
Analyst Upgrade
Analyst Revision
Danaher Co. stock logo
DHR
Danaher
$184.79
-1.4%
35.00$132.25 billion2.81 million3.47 millionPositive News
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$436.00
+0.5%
N/A$111.96 billion1.43 million1.42 millionPositive News
GSK plc stock logo
GSK
GSK
$38.70
-0.6%
24.34$79.84 billion3.67 million4.83 millionTrending News
Analyst Revision
Cencora, Inc. stock logo
COR
Cencora
$292.23
+0.7%
41.57$56.64 billion1.36 million1.54 millionPositive News
Takeda Pharmaceutical Company Limited stock logo
TAK
Takeda Pharmaceutical
$14.58
+1.1%
36.44$46.38 billion1.99 million1.93 millionPositive News
Cognizant Technology Solutions Co. stock logo
CTSH
Cognizant Technology Solutions
$79.12
-1.0%
17.54$39.00 billion2.24 million3.57 millionPositive News
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
$233.41
-0.9%
57.63$37.97 billion858,4551.11 millionNews Coverage
Positive News
Upcoming Earnings
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$289.96
+0.3%
N/A$37.81 billion757,018917,014Positive News
argenx SE stock logo
ARGX
argenx
$587.61
+1.1%
N/A$35.88 billion227,615324,850Positive News
Analyst Forecast
BioNTech SE stock logo
BNTX
BioNTech
$98.68
-0.4%
N/A$23.72 billion598,407921,427Positive News
Analyst Forecast
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$136.96
-0.8%
18.26$23.69 billion2.25 million1.56 millionPositive News
Analyst Forecast
International Flavors & Fragrances Inc. stock logo
IFF
International Flavors & Fragrances
$75.03
-0.9%
79.82$19.19 billion1.40 million1.52 millionPositive News
Insider Trade
Analyst Revision
Royalty Pharma plc stock logo
RPRX
Royalty Pharma
$32.45
+0.4%
22.38$18.63 billion2.51 million3.47 millionNews Coverage
Positive News
Analyst Downgrade
United Therapeutics Co. stock logo
UTHR
United Therapeutics
$307.65
-0.3%
13.51$13.88 billion269,594442,590Positive News
Analyst Revision
Illumina, Inc. stock logo
ILMN
Illumina
$80.37
-0.2%
N/A$12.75 billion1.54 million2.32 millionAnalyst Forecast
Gap Down
Suzano S.A. stock logo
SUZ
Suzano
$9.38
-0.3%
14.88$12.41 billion1.19 million1.80 millionPositive News
Revvity, Inc. stock logo
RVTY
Revvity
$89.47
-1.1%
40.48$10.55 billion1.02 million950,377Trending News
Analyst Revision
Gap Down
ICON Public Limited stock logo
ICLR
ICON Public
$127.99
+0.8%
13.43$10.34 billion883,2761.05 million
Moderna, Inc. stock logo
MRNA
Moderna
$26.26
-1.7%
N/A$10.16 billion8.24 million8.00 millionTrending News
Analyst Forecast
Gap Down
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$294.89
+0.6%
23.35$8.48 billion266,217353,489Positive News
Fabrinet stock logo
FN
Fabrinet
$230.41
+0.9%
25.77$8.26 billion542,948627,546Positive News
Analyst Revision
Gap Down
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
$250.08
N/A$7.00 billion3223
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$136.76
+0.9%
911.73$6.72 billion775,603991,241Positive News
Analyst Upgrade
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
$34.57
+1.0%
N/A$5.49 billion1.04 million2.98 millionPositive News
Legend Biotech Co. stock logo
LEGN
Legend Biotech
$28.91
-0.5%
N/A$5.31 billion1.51 million1.29 million
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$121.25
-0.1%
23.96$5.30 billion732,6511.40 million
Lumentum Holdings Inc. stock logo
LITE
Lumentum
$75.77
-0.1%
N/A$5.26 billion1.13 million1.99 millionPositive News
Gap Down
Bloom Energy Co. stock logo
BE
Bloom Energy
$19.50
+6.2%
N/A$4.27 billion5.07 million6.64 millionPositive News
Gap Down
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$32.54
-4.2%
N/A$4.20 billion1.76 million1.37 millionPositive News
Gap Down
Oddity Tech Ltd. stock logo
ODD
Oddity Tech
$69.65
+1.5%
42.47$3.89 billion909,551557,265Positive News
Gap Down
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$125.05
-0.2%
41.82$3.61 billion298,645307,417Positive News
SpringWorks Therapeutics, Inc. stock logo
SWTX
SpringWorks Therapeutics
$46.48
+0.5%
N/A$3.49 billion5.93 million2.17 millionPositive News
High Trading Volume
Hercules Capital, Inc. stock logo
HTGC
Hercules Capital
$17.40
+0.5%
10.81$3.05 billion987,8791.09 millionPositive News
Ascentage Pharma Group International stock logo
AAPG
Ascentage Pharma Group International
$26.48
+3.6%
N/A$2.31 billion19,84962,291News Coverage
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
$2.53
-5.6%
N/A$2.23 billion6.25 million5.57 millionAnalyst Upgrade
Gap Down
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$10.59
+1.9%
N/A$2.22 billion3.61 million3.02 millionPositive News
Analyst Upgrade
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
$13.42
-1.8%
N/A$1.95 billion786,2741.10 millionGap Down
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
$6.22
-0.6%
N/A$1.92 billion2.82 million2.84 millionPositive News
We’ve Entered the Most Bullish Phase of the Cycle (Ad)

It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.

The Most Profitable Phase of Crypto Just Started - PLUS Claim your $10 in Bitcoin
Galapagos NV stock logo
GLPG
Galapagos
$28.73
-0.2%
N/A$1.89 billion210,690239,605Positive News
Tutor Perini Co. stock logo
TPC
Tutor Perini
$35.82
+1.8%
N/A$1.89 billion452,066548,000
Apogee Therapeutics, Inc. stock logo
APGE
Apogee Therapeutics
$39.48
-2.2%
N/A$1.82 billion405,796523,828Positive News
Gap Down
Standex International Co. stock logo
SXI
Standex International
$145.88
-1.0%
31.85$1.76 billion65,09356,804Positive News
Twist Bioscience Co. stock logo
TWST
Twist Bioscience
$28.26
+0.4%
N/A$1.69 billion781,842976,364Trending News
Gap Down
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$16.83
-2.4%
N/A$1.69 billion962,0091.45 millionPositive News
Gap Down
Evotec SE stock logo
EVO
Evotec
$4.73
+17.4%
N/A$1.68 billion530,776131,637Positive News
Gap Up
High Trading Volume
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$4.08
-1.4%
N/A$1.66 billion16.65 million13.39 millionPositive News
Gap Down
JPMorgan U.S. Tech Leaders ETF stock logo
JTEK
JPMorgan U.S. Tech Leaders ETF
$76.08
-0.6%
35.61$1.56 billion255,765258,014
Immunocore Holdings plc stock logo
IMCR
Immunocore
$31.16
-0.2%
N/A$1.56 billion98,828407,682Positive News
Phreesia, Inc. stock logo
PHR
Phreesia
$24.07
-1.1%
N/A$1.43 billion242,602438,719News Coverage
Positive News
Upcoming Earnings
Gap Down
Adaptive Biotechnologies Co. stock logo
ADPT
Adaptive Biotechnologies
$8.93
+1.0%
N/A$1.36 billion1.01 million1.58 millionPositive News
Gap Down
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$11.69
-1.8%
N/A$1.33 billion1.47 million1.64 millionPositive News
Gap Down
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
$19.64
+0.1%
N/A$1.25 billion1.06 million782,749Positive News
Oaktree Specialty Lending Co. stock logo
OCSL
Oaktree Specialty Lending
$14.10
+0.5%
21.05$1.24 billion312,354755,239Positive News
Azenta, Inc. stock logo
AZTA
Azenta
$27.00
-3.7%
N/A$1.24 billion865,146689,311Positive News
Gap Down
Novavax, Inc. stock logo
NVAX
Novavax
$7.25
-0.5%
N/A$1.17 billion5.57 million7.29 millionOptions Volume
Gap Down
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$13.57
-0.7%
N/A$1.11 billion645,4301.19 millionPositive News
Analyst Forecast
Gap Down
Redwire Co. stock logo
RDW
Redwire
$12.98
+2.1%
N/A$1.00 billion1.64 million1.07 millionAnalyst Upgrade
10x Genomics, Inc. stock logo
TXG
10x Genomics
$8.17
-4.3%
N/A$999.21 million1.80 million2.39 millionAnalyst Upgrade
Gap Down
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
$5.95
-2.3%
N/A$917.10 million1.01 million1.29 millionPositive News
Gap Down
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$15.01
-0.4%
N/A$904.74 million210,288612,418Positive News
Gap Down
SLR Investment Corp. stock logo
SLRC
SLR Investment
$16.42
+0.7%
9.28$895.88 million88,952164,722
Thermon Group Holdings, Inc. stock logo
THR
Thermon Group
$26.51
-8.2%
19.49$893.22 million378,729169,667Trending News
Earnings Report
Upcoming Earnings
High Trading Volume
Transcat, Inc. stock logo
TRNS
Transcat
$91.32
-0.3%
49.36$850.10 million70,64381,969Trending News
Earnings Report
Analyst Upgrade
Analyst Revision
Abrdn Healthcare Investors stock logo
HQH
Abrdn Healthcare Investors
$15.26
-1.2%
N/A$821.93 million195,735190,168Positive News
Dividend Increase
Zymeworks Inc. stock logo
ZYME
Zymeworks
$11.54
+0.5%
N/A$802.92 million349,420599,455News Coverage
Analyst Forecast
Analyst Revision
Avid Bioservices, Inc. stock logo
CDMO
Avid Bioservices
$12.50
+0.1%
N/A$799.18 million3.07 million1.36 millionHigh Trading Volume
Diversified Healthcare Trust stock logo
DHC
Diversified Healthcare Trust
$3.14
+4.3%
N/A$757.53 million712,1331.00 millionNews Coverage
Positive News
Analyst Revision
Immunome, Inc. stock logo
IMNM
Immunome
$8.49
+0.4%
N/A$738.73 million527,133916,520Positive News
Analyst Upgrade
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$6.27
-4.4%
N/A$669.55 million2.08 million1.51 millionPositive News
Gap Down
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$33.04
+1.7%
82.60$664.47 million353,098216,421Positive News
BlackRock TCP Capital Corp. stock logo
TCPC
BlackRock TCP Capital
$7.69
+1.9%
N/A$653.94 million488,208589,482News Coverage
Analyst Upgrade
Replimune Group, Inc. stock logo
REPL
Replimune Group
$8.35
-4.7%
N/A$643.08 million1.46 million926,127Trending News
Earnings Report
Insider Trade
Options Volume
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$4.50
-2.4%
N/A$622.07 million1.38 million1.38 millionNews Coverage
Positive News
Analyst Forecast
Analyst Revision
Gap Down
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
$20.44
-1.4%
N/A$600.53 million357,651600,947Positive News
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$1.78
+1.7%
N/A$594.40 million7.85 million8.64 millionTrending News
Gap Down
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
$18.42
+0.3%
N/A$592.39 million234,992273,124Gap Down
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$4.82
-2.6%
N/A$548.79 million877,1721.26 millionNews Coverage
Positive News
Analyst Forecast
Analyst Revision
Gap Down
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$9.29
-3.1%
N/A$493.21 million189,305263,849News Coverage
Positive News
Analyst Forecast
Analyst Revision
Gap Down
Upstream Bio, Inc. stock logo
UPB
Upstream Bio
$9.16
-1.6%
N/A$492.75 million284,858327,321Gap Down
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$9.71
-1.5%
N/A$487.05 million645,180880,673Analyst Revision
Gap Down
Arvinas, Inc. stock logo
ARVN
Arvinas
$6.51
+0.6%
N/A$475.17 million1.24 million1.34 millionGap Down
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$5.31
-0.9%
N/A$473.34 million906,4931.22 million
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
$10.25
-5.6%
N/A$468.19 million1.67 million1.73 millionTrending News
Analyst Forecast
Analyst Revision
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
$1.99
-0.5%
N/A$448.70 million2.31 million3.42 millionGap Down
PureTech Health plc stock logo
PRTC
PureTech Health
$18.20
-4.2%
N/A$437.15 million1,3764,708Positive News
Gap Down
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$10.95
-2.1%
N/A$409.98 million135,502225,915News Coverage
Analyst Upgrade
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$6.99
+2.0%
N/A$409.14 million1.03 million1.46 million
Septerna, Inc. stock logo
SEPN
Septerna
$9.19
-3.1%
N/A$409.10 million372,784714,643Analyst Revision
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
Zhengye Biotechnology Holding Limited stock logo
ZYBT
Zhengye Biotechnology
$8.53
-12.3%
N/A$402.33 million798,045354,029News Coverage
Gap Down
High Trading Volume
Celcuity Inc. stock logo
CELC
Celcuity
$10.44
-2.9%
N/A$395.32 million144,757298,558News Coverage
Analyst Revision
Rapport Therapeutics stock logo
RAPP
Rapport Therapeutics
$10.82
-2.7%
N/A$394.91 million206,082174,806
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
$15.32
+0.3%
N/A$393.49 million142,435275,981
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
$7.89
+0.1%
N/A$368.24 million3.70 million634,521Trending News
Analyst Downgrade
Analyst Revision
High Trading Volume
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$4.06
-4.2%
N/A$367.43 million2.42 million1.79 millionPositive News
Analyst Forecast
Gap Down
Wabash National Co. stock logo
WNC
Wabash National
$8.66
-2.0%
N/A$362.64 million393,243794,475
Runway Growth Finance Corp. stock logo
RWAY
Runway Growth Finance
$9.69
+0.9%
9.32$361.89 million242,810316,457Positive News
ABIVAX Société Anonyme stock logo
ABVX
ABIVAX Société Anonyme
$5.67
-6.3%
N/A$359.59 million264,215139,143Positive News
Gap Down
Abrdn Life Sciences Investors stock logo
HQL
Abrdn Life Sciences Investors
$12.33
+1.3%
N/A$355.99 million67,599105,013News Coverage
Dividend Announcement
Insider Trade

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.